The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Redefined

Myalgic Encephalomyelitis/Chronic Fatigue Syndrome Redefined

June 15, 2015 • By Karen Appold

  • Tweet
  • Email
Print-Friendly Version / Save PDF
THPStock/SHUTTERSTOCK.COM

Image Credit: THPStock/SHUTTERSTOCK.COM

A report from the Institute of Medicine that gives new diagnostic criteria for myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and recommends a new name for the disorder received mixed reviews from rheumatologists and other physicians.1

You Might Also Like
  • A Rose by Any Other Name: Why clinicians & patients prefer the term myalgic encephalomyelitis & other updates on chronic fatigue syndrome
  • Chronic Fatigue Syndrome: Why Myalgic Encephalomyelitis Is the Preferred Term and More
  • Scientists May Be Closer to A Blood Test for Chronic Fatigue Syndrome
Explore This Issue
June 2015
Also By This Author
  • How to Thrive—Not Just Survive—as a New Manager, Part 2

“Diagnosing ME/CFS often is a challenge … the new diagnostic criteria will make it easier for clinicians to recognize and accurately diagnose patients in a timely manner, as well as allow a large percentage of currently undiagnosed patients to receive appropriate care,” says the chair of the committee that wrote the report, Ellen Wright Clayton, who is the Craig-Weaver Professor of Pediatrics and professor of law at Vanderbilt University.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The committee recommended that physicians diagnose ME/CFS if certain diagnostic criteria are met following an appropriate history, physical examination and medical workup. Diagnosis of ME/CFS would require three core symptoms:

  • A substantial reduction or impairment in the ability to engage in pre-illness levels of activities that persists for more than six months and is accompanied by fatigue of new or definite onset;
  • The worsening of a patients’ symptoms after any type of exertion, such as physical, cognitive or emotional stress; and
  • Unrefreshing sleep.

In addition, the patient must either have cognitive impairment and/or be unable to remain upright, with symptoms that improve when lying down (orthostatic intolerance).

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

Stuart Kaplan, MD, partner, Rheumatology Consultants LLP, Hewlett, N.Y., and chief, Division of Rheumatology, South Nassau Communities Hospital, Oceanside, N.Y., believes patients will benefit from the new criteria by now being able to prove that they have a serious, potentially debilitating disease. “This will allow them to obtain the benefits and treatments they deserve,” he says. “Having criteria for fibromyalgia has made a tremendous difference for those patients. Often, just telling the patient that you know what they have and showing them how they fit the criteria for a specific disease, alleviates much of the suffering of these patients, many of whom have been told they are crazy or malingering.”

On the other hand, Robert G. Lahita, MD, PhD, FACP, MACR, FRCP, chair of medicine and vice president, Newark Beth Israel Medical Center, and professor of medicine, Rutgers, New Jersey Medical School, says the new criteria are broad and ambiguous. “Cognitive impairment is common to many illnesses, and the inability to remain upright is quite general. Postexertional malaise and unrefreshing sleep are also aspects of chronic rheumatic diseases, such as lupus, fibromyalgia and rheumatoid arthritis. There will be considerable overlap.”

Pages: 1 2 3 4 | Single Page

Filed Under: Conditions Tagged With: chronic fatigue syndrome, Diagnostic Criteria, Institute of Medicine, myalgic encephalomyelitis, patient care, recommendation, ResearchIssue: June 2015

You Might Also Like:
  • A Rose by Any Other Name: Why clinicians & patients prefer the term myalgic encephalomyelitis & other updates on chronic fatigue syndrome
  • Chronic Fatigue Syndrome: Why Myalgic Encephalomyelitis Is the Preferred Term and More
  • Scientists May Be Closer to A Blood Test for Chronic Fatigue Syndrome
  • Chronic Fatigue Syndrome: Are There Different Phenotypes?

Meeting Abstracts

Browse and search abstracts from the ACR Convergence and ACR/ARP Annual Meetings going back to 2012.

Visit the Abstracts site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.